Drug · DIN 02345129
ROPINIROLE
No: cancelled before it was sold
Authorized, then cancelled before it was ever sold in Canada.
Status Cancelled Pre Market since September 1, 2017.
- Drug Identification Number (DIN)
- 02345129
- Company (DIN owner)
- Cobalt Pharmaceuticals IncorporatedToronto, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Ropinirole N04BC04
- Class
- Human
- Record last updated
- June 25, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| ROPINIROLE (ROPINIROLE HYDROCHLORIDE) | 0.25 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- March 16, 2010: NOC 11149Abbreviated New Drug Submission (ANDS) · Additional product name
Other DINs named ROPINIROLE
- DIN 02345137 · Cancelled Pre Market
- DIN 02345145 · Cancelled Pre Market
- DIN 02345153 · Cancelled Pre Market
- DIN 02353040 · Cancelled Post Market
- DIN 02353059 · Cancelled Post Market
- DIN 02353067 · Cancelled Post Market
- DIN 02353075 · Cancelled Post Market